Abstract
Although natural products and synthetic small molecules both serve important medicinal functions, their structures and chemical properties are relatively distinct. To expand the molecular diversity available for drug discovery, one strategy is to blend the effective attributes of synthetic and natural molecules. A key feature found in synthetic compounds that is rare in nature is the use of fluorine to tune drug behavior. We now report a method to site-selectively incorporate fluorine into complex structures to produce regioselectively fluorinated full-length polyketides. We engineered a fluorine-selective trans-acyltransferase to produce site-selectively fluorinated erythromycin precursors in vitro. We further demonstrated that these analogs could be produced in vivo in Escherichia coli on engineering of the fluorinated extender unit pool. By using engineered microbes, elaborate fluorinated compounds can be produced by fermentation, offering the potential for expanding the identification and development of bioactive fluorinated small molecules.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
Source data are provided with this paper. All data associated with this study are contained in the published article or are available from the corresponding author upon reasonable request.
References
Clardy, J. & Walsh, C. Lessons from natural molecules. Nature 432, 829–837 (2004).
Karageorgis, G., Foley, D. J., Laraia, L. & Waldmann, H. Principle and design of pseudo-natural products. Nat. Chem. 12, 227–235 (2020).
Rodrigues, T., Reker, D., Schneider, P. & Schneider, G. Counting on natural products for drug design. Nat. Chem. 8, 531–541 (2016).
Luo, X. et al. Complete biosynthesis of cannabinoids and their unnatural analogues in yeast. Nature 567, 123–126 (2019).
Stratton, C. F., Newman, D. J. & Tan, D. S. Cheminformatic comparison of approved drugs from natural product versus synthetic origins. Bioorg. Med. Chem. Lett. 25, 4802–4807 (2015).
Ertl, P. & Schuhmann, T. A systematic cheminformatics analysis of functional groups occurring in natural products. J. Nat. Prod. 82, 1258–1263 (2019).
Müller, K., Faeh, C. & Diederich, F. Fluorine in pharmaceuticals: looking beyond intuition. Science 317, 1881–1886 (2007).
Wang, J. et al. Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001–2011). Chem. Rev. 114, 2432–2506 (2014).
O’Hagan, D. & Deng, H. Enzymatic fluorination and biotechnological developments of the fluorinase. Chem. Rev. 115, 634–649 (2015).
Purser, S., Moore, P. R., Swallow, S. & Gouverneur, V. Fluorine in medicinal chemistry. Chem. Soc. Rev. 37, 320–330 (2008).
Cheng, Q. & Ritter, T. New directions in C–H fluorination. TRECHEM 1, 461–470 (2019).
Hull, K. L., Anani, W. Q. & Sanford, M. S. Palladium-catalyzed fluorination of carbon-hydrogen bonds. J. Am. Chem. Soc. 128, 7134–7135 (2006).
Cho, E. J. et al. The palladium-catalyzed trifluoromethylation of aryl chlorides. Science 328, 1679–1681 (2010).
Scattolin, T., Bouayad-Gervais, S. & Schoenebeck, F. Straightforward access to N-trifluoromethyl amides, carbamates, thiocarbamates and ureas. Nature 573, 102–107 (2019).
Roque, J. B., Kuroda, Y., Göttemann, L. T. & Sarpong, R. Deconstructive fluorination of cyclic amines by carbon-carbon cleavage. Science 361, 171–174 (2018).
Planas, O., Wang, F., Leutzsch, M. & Cornella, J. Fluorination of arylboronic esters enabled by bismuth redox catalysis. Science 367, 313–317 (2020).
Eustáquio, A. S., O’Hagan, D. & Moore, B. S. Engineering fluorometabolite production: fluorinase expression in Salinispora tropica yields fluorosalinosporamide. J. Nat. Prod. 73, 378–382 (2010).
Newman, D. J. & Cragg, G. M. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J. Nat. Prod. 83, 770–803 (2020).
Peralta-Yahya, P. P., Zhang, F., del Cardayre, S. B. & Keasling, J. D. Microbial engineering for the production of advanced biofuels. Nature 488, 320–328 (2012).
Choi, Y. J. & Lee, S. Y. Microbial production of short-chain alkanes. Nature 502, 571–574 (2013).
Hug, J. J., Krug, D. & Müller, R. Bacteria as genetically programmable producers of bioactive natural products. Nat. Rev. Chem. 4, 172–193 (2020).
Ro, D. K. et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440, 940–943 (2006).
Niquille, D. L. et al. Nonribosomal biosynthesis of backbone-modified peptides. Nat. Chem. 10, 282–287 (2018).
Hertweck, C. The biosynthetic logic of polyketide diversity. Angew. Chem. Int. Ed. Engl. 48, 4688–4716 (2009).
Staunton, J. & Weissman, K. J. Polyketide biosynthesis: a millennium review. Nat. Prod. Rep. 18, 380–416 (2001).
Wilson, M. C. & Moore, B. S. Beyond ethylmalonyl-CoA: the functional role of crotonyl-CoA carboxylase/reductase homologs in expanding polyketide diversity. Nat. Prod. Rep. 29, 72–86 (2012).
Ray, L. & Moore, B. S. Recent advances in the biosynthesis of unusual polyketide synthase substrates. Nat. Prod. Rep. 33, 150–161 (2016).
Walker, M. C. et al. Expanding the fluorine chemistry of living systems using engineered polyketide synthase pathways. Science 341, 1089–1094 (2013).
Dunn, B. J., Watts, K. R., Robbins, T., Cane, D. E. & Khosla, C. Comparative analysis of the substrate specificity of trans- versus cis-acyltransferases of assembly line polyketide synthases. Biochemistry 53, 3796–3806 (2014).
Musiol-Kroll, E. M. et al. Polyketide bioderivatization using the promiscuous acyltransferase KirCII. ACS Synth. Biol. 6, 421–427 (2017).
Carvalho, R., Reid, R., Viswanathan, N., Gramajo, H. & Julien, B. The biosynthetic genes for disorazoles, potent cytotoxic compounds that disrupt microtubule formation. Gene 359, 91–98 (2005).
Khosla, C., Tang, Y., Chen, A. Y., Schnarr, N. A. & Cane, D. E. Structure and mechanism of the 6-deoxyerythronolide B synthase. Ann. Rev. Biochem. 76, 195–221 (2007).
Zha, W., Rubin-Pitel, S. B., Shao, Z. & Zhao, H. Improving cellular malonyl-CoA level in Escherichia coli via metabolic engineering. Metab. Eng. 11, 192–198 (2009).
Mathews, I. I. et al. The conformational flexibility of the acyltransferase from the disorazole polyketide synthase is revealed by an X-ray free-electron laser using a room-temperature sample delivery method for serial crystallography. Biochemistry 56, 4751–4756 (2017).
Yadav, G., Gokhale, R. S. & Mohanty, D. Computational approach for prediction of domain organization and substrate specificity of modular polyketide synthases. J. Mol. Biol. 328, 335–363 (2003).
Starcevic, A. et al. ClustScan: an integrated program package for the semi-automatic annotation of modular biosynthetic gene clusters and in silico prediction of novel chemical structures. Nucleic Acids Res. 36, 6882–6892 (2008).
Gokhale, R. S., Tsuji, S. Y., Cane, D. E. & Khosla, C. Dissecting and exploiting intermodular communication in polyketide synthases. Science 284, 482–485 (1999).
Lowry, B. et al. In vitro reconstituÿtion and analysis of the 6-deoxyerythronolide B synthase. J. Am. Chem. Soc. 135, 16809–16812 (2013).
Ashley, G. W. & Carney, J. R. API-mass spectrometry of polyketides. II. Fragmentation analysis of 6-deoxyerythronolide B analogs. J. Antibiot. 57, 579–589 (2004).
Wong, F. T., Chen, A. Y., Cane, D. E. & Khosla, C. Protein–protein recognition between acyltransferases and acyl carrier proteins in multimodular polyketide synthases. Biochemistry 49, 95–102 (2010).
Thuronyi, B. W., Privalsky, T. M. & Chang, M. C. Y. Engineered fluorine metabolism and fluoropolymer production in living cells. Angew. Chem. Int. Ed. Engl. 56, 13637–13640 (2017).
Ad, O., Thuronyi, B. W. & Chang, M. C. Y. Elucidating the mechanism of fluorinated extender unit loading for improved production of fluorine-containing polyketides. Proc. Natl Acad. Sci. USA 114, E660–E668 (2017).
Pfeifer, B. A., Admiraal, S. J., Gramajo, H., Cane, D. E. & Khosla, C. Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. Science 291, 1790–1792 (2001).
Dong, H., Liffland, S., Hillmyer, M. A. & Chang, M. C. Y. Engineering in vivo production of à-branched polyesters. J. Am. Chem. Soc. 141, 16877–16883 (2019).
Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6, 343–345 (2009).
Bonnett, S. et al. Acyl-CoA subunit selectivity in the pikromycin polyketide synthase PikAIV: steady-state kinetics and active-site occupancy analysis by FTICR-MS. Chem. Biol. 18, 1075–1081 (2011).
Piasecki, S. K. et al. Employing modular polyketide synthase ketoreductases as biocatalysts in the preparative chemoenzymatic syntheses of diketide chiral building blocks. Chem. Biol. 18, 1331–1340 (2011).
Ushimaru, K., Sangiambut, S., Thomson, N., Sivaniah, E. & Tsuge, T. New insights into activation and substrate recognition of polyhydroxyalkanoate synthase from Ralstonia eutropha. Appl. Microbiol. Biotechnol. 97, 1175–1182 (2013).
Jia, K., Cao, R., Hua, D. H. & Li, P. Study of Class I and Class III polyhydroxyalkanoate (PHA) synthases with substrates containing a modified side chain. Biomacromolecules 17, 1477–1485 (2016).
Wodzinska, J. et al. Polyhydroxybutyrate synthase: evidence for covalent catalysis. J. Am. Chem. Soc. 118, 6319–6320 (1996).
Molnos, J., Gardiner, R., Dale, G. E. & Lange, R. A continuous coupled enzyme assay for bacterial malonyl-CoA:acyl carrier protein transacylase (FabD). Anal. Biochem. 319, 171–176 (2003).
Dunn, B. J., Cane, D. E. & Khosla, C. Mechanism and specificity of an acyltransferase domain from a modular polyketide synthase. Biochemistry 52, 1839–1841 (2013).
Pistorino, M. & Pfeifer, B. A. Efficient experimental design and micro-scale medium enhancement of 6-deoxyerythronolide B production through Escherichia coli. Biotechnol. Prog. 25, 1364–1371 (2009).
Kosol, S., Jenner, M., Lewandowski, J. R. & Challis, G. L. Protein–protein interactions in trans-AT polyketide synthases. Nat. Prod. Rep. 35, 1097–1109 (2018).
Ocampo, R., Dolbier, W. R., Abboud, K. A. & Zuluaga, F. Catalyzed Reformatsky reactions with ethyl bromofluoroacetate for the synthesis of α-fluoro-β-hydroxy acids. J. Org. Chem. 67, 72–78 (2002).
Acknowledgements
We thank the Pfeifer laboratory at University at Buffalo, The State University of New York for pBP130 and pBP144 plasmids. We thank J. Fang for helpful discussions as well as the C. Chang, Zhang and Francis laboratories at UCB for use of equipment. This work was supported by grant nos. NIH 1 R01 GM123181-01 (M.C.Y.C.) and NIH 1 R35 GM141799 (C.K.). S.S. and O.A. acknowledge the support of a National Institutes of Health NRSA Training grant 1 T32 GM066698. H.D. acknowledges the UC Berkeley Tang Distinguished Scholars Program for a postdoctoral fellowship. Instruments in the UC Berkeley College of Chemistry NMR Facility were supported in part by grant no. NIH S10OD024998.
Author information
Authors and Affiliations
Contributions
S.S. performed in vivo polyketide production experiments, enzyme characterization experiments, physiological experiments and construction of DNAs with S.R. O.A. synthesized TKL standards and carried out DszAT library generation and screening with J.L.S. T.M.P. and S.S. jointly performed in vitro polyketide production experiments. H.D. assisted with construction of DNAs. E.E.K.B. and B.A. assisted with high-resolution fragmentation analysis of 6dEB and its analogs. M.C.Y.C. and C.K. administered the project. S.S. and M.C.Y.C. wrote the paper with contributions from all authors. All authors designed experiments and analyzed data.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Chemical Biology thanks Constance Bailey and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 trans-AT library screening.
(A) Lysate of E. coli expressing following DszAT mutants were screened through the triketide lactone production assay with purified Mod3DEBS + TE(AT0) protein, malonate or fluoromalonate extender unit, malonate-coeznzyme A ligase MatB and NDK-SNAC: 1, F190A; 2, F190C; 3, F190D; 4, F190E; 5, F190G; 6, F190H; 7, F190I; 8, F190K; 9, F190L; 10, F190M; 11, F190N; 12, F190P; 13, F190Q; 14, F190R; 15, F190S; 16, F190T; 17, F190V; 18, F190W; 19, F190Y; 21, F190G L87V; 22, F190G L87A; 23, F190I L87V; 24, F190I L87A; 25, F190P L87A; 26, F190S L87V; 27, F190S L87A; 28, F190T L87V; 29, F190T L87A; 30, F190V L87V; 31, F190V L87A. Product formation was monitored by LC-QQQ using negative ionization mode (transition): F-TKL (173→59), H-TKL (155→97), H-TTKP (197→95), TKL (169→111). The amounts of F-TKL (red), H-TKL (black), and H-TTKP (gray) products were determined by integrating extracted ion counts for the relevant species and are shown normalized by the amount of corresponding product produced by wild-type enzyme. H-TTKP arises from two chain extensions with malonyl-CoA. Mutants that showed potentially increased selectivity towards fluoromalonyl-CoA (underlined) compared to wild-type enzyme were selected for in vitro screening. (B) Selected DszAT mutants from lysate screen (F190G, F190T, F190V, F190P L87A and F190I L87A) were overexpressed, purified and assessed through in vitro triketide lactone experiment with purified Mod3DEBS + TE(AT0) protein, MatB and NDK-SNAC for the production of H-TKL and H-TTKP from malonyl-CoA (top panels), F-TKL from fluoromalonyl-CoA (bottom left) and TKL from methylmalonyl-CoA (bottom right). The amounts of products were determined as in (A). Data are mean of two technical replicates.
Extended Data Fig. 2 Characterization of DszAT F190V.
(A) Steady-state kinetic analysis of transacylation reaction of malonyl-CoA (left), methylmalonyl-CoA (middle) and fluoromalonyl-CoA (right) by wild-type (black) and F190V (red) DszAT with 75 uM of ACPDEBSMod6 as acyl accepter. Transacylation activity was measured by α-ketoglutarate dehydrogenase coupled assay monitoring CoA release. The dose-response curves for transacylation of methylmalonyl-CoA by WT and F190V DszAT were fit with Michaelis-Menten equation. The dose-response curves for WT and F190V DszAT transacylation with malonyl- and fluoromalonyl-CoA exhibited sigmoidal behavior with evidence of inhibition at high substrate concentrations and were therefore fit with the Hill equation modified for substrate inhibition. Data shown are mean ± s.d. of three technical replicates. (B) Steady-state kinetic analysis of hydrolysis reaction of fluoromalonyl-CoA by wild-type and F190V DszAT. Hydrolytic activity was measured by DTNB assay monitoring CoA release. The dose-response curves were obtained from non-linear fitting of data to Michaelis-Menten equation. Data points are mean ± s.d. of three technical replicates.
Extended Data Fig. 3 Generation of 2-fluoro-2-desmethyl-6dEB analog through in vitro reconstitution of Mod6 AT0 DEBS.
(A) Extracted ion chromatograms showing exact mass of in vitro production of monofluorinated desmethyl 6dEB by Mod6 AT0 DEBS complemented with WT DszAT (left) or F190V DszAT (right). Reactions containing 2 μM each of LDDDEBS, Mod1DEBS, Mod2DEBS, DEBS2 and DEBS3(Mod6 AT0), 6 μM WT or F190V DszAT, 2 mM methylmalonate and when used 10 mM fluoromalonate (+Fmal, red) were analyzed by LC-QTOF. Chromatograms are representative of at least three technical replicates. (B) Fragmentation pattern of the monofluorinated desmethyl 6dEB analog produced by Mod6 AT0 DEBS complemented by WT DszAT or F190V DszAT is consistent with 2-fluoro-2-desmethyl 6dEB, which is expected when fluoromalonyl-CoA is incorporated by module 6. Fragmentation pattern shows presence of ions in A, B and D families (Supplementary Fig. 5) with mass shifts according to a substitution of -CH3 with -F group on carbon 2, 4, 6 or 8 of 6dEB. Observed loss of HF from daughter ions expected to contain fluorine substitution further supports the presence of fluorine in the molecule. Notably, the most prominent fragment in 6dEB MS/MS spectrum, the C ion, was entirely missing in the MS/MS spectrum of the monofluorinated desmethyl 6dEB analog39. This lack of detectable fragment prevents narrowing down the definite location of the fluorine substitution. However, the suppression of ion C was similarly observed when malonate was provided to the system in place of fluoromalonate (Supplementary Fig. 6) and is consistent with the reactivity of 6dEB analog with a modification near the C3 position. The lack of methyl substituent at C2 as in 2-fluoro-2-methyl 6dEB would reduce the reactivity of A ion with respect to the hydride shift from C3 to C9 necessary to form C ion. Spectra are representative of at least three technical replicates (nd, not detected). (C) Relative amounts of 2-fluoro-2-desmethyl 6dEB and 6dEB by complementation of Mod6 AT0 DEBS by WT or F190V DszAT. The amounts of products were determined by integrating extracted ion counts for the relevant species monitored by LC-QQQ (transition): 6dEB (369.2→239.1) and 2-fluoro-2-desmethyl 6dEB (373.2 → 275.1). Although the absolute amounts of the two observed products vary among replicates; F190V DszAT reactions consistently produce higher ratio of fluorinated to non-fluorinated product than WT DszAT.
Extended Data Fig. 4 Generation of 4-fluoro-4-desmethyl-6dEB analog through in vitro reconstitution of Mod5 AT0 DEBS.
(A) Extracted ion chromatograms showing exact mass of in vitro production of monofluorinated desmethyl 6dEB by Mod5 AT0 DEBS complemented with WT DszAT (left) or F190V DszAT (right). Reactions containing 2 μM each of LDDDEBS, Mod1DEBS, Mod2DEBS, DEBS2 and DEBS3(Mod5 AT0), 6 μM WT or F190V DszAT, 2 mM methylmalonate and when used 10 mM fluoromalonate (+Fmal, red) were analyzed by LC-QTOF. Chromatograms are representative of at least three technical replicates. (B) Fragmentation pattern of the monofluorinated desmethyl 6dEB analog produced by Mod5 AT0 DEBS complemented by WT DszAT or F190V DszAT is consistent with 4-fluoro-4-desmethyl 6dEB, which is expected when fluoromalonyl-CoA is incorporated by Mod5. The observed daughter ion masses are necessarily similar to those of 2-fluoro-2-desmethyl 6dEB observed in Mod6 AT0 DEBS system, due to fluorine substitution in similar positions. In short, mass shifts according to a substitution of -CH3 with -F group on carbon 2, 4, 6 or 8 of 6dEB, loss of HF from daughter ions and absence of C ion are observed. Spectra are representative of at least three technical replicates (nd, not detected). (C) Relative amounts of 4-fluoro-4-desmethyl 6dEB and 6dEB by complementation of Mod5 AT0 DEBS by WT or F190V DszAT. The amounts of products were determined by integrating extracted ion counts for the relevant species monitored by LC-QQQ (transition): 6dEB (369.2 → 239.1) and 2-fluoro-2-desmethyl 6dEB (373.2 → 275.1).
Extended Data Fig. 5 Sequence and structural analysis of E. coli FabD.
(A) Sequence comparison between FabD and DszAT. Conserved functional residues are shown in red; specificity-determining residue are shown in blue; and ACP-interacting residues are shown in green. (B) Structural comparison between Fab (blue) and DszAT (grey). The two proteins have the same overall structure (left, rmsd = 1.7 Å), active site architecture (middle) and ACP-interacting surface (right). Both proteins contain two subdomains with the active site in between. The substrate-binding pocket is largely polar. In both structures, malonate is bound by salt bridge interactions between its β-carboxy group and the side chain amine groups of R117/R111, positioning the carbonyl carbon for nucleophilic attack near the catalytic serine S84/S92, which is found in nearly identical position in both proteins. Notably, in DszAT, F190 is found positioned near the Cα of malonate that may prevent binding of substrate with bulkier substituent such as a methyl group at the α-position. In FabD, this residue is replaced with S200, which may provide more flexibility in terms of substrate binding. Interactions between AT and ACP domains has previously been shown to rely on a small number of charged amino acid residues located near the active sites of the two protein domains40,54. R278 and R279 of DszAT interact with E70 of its native protein partner, DSZS ACP1. Similarly, K180 of DszAT interacts with D45 of DSZS ACP1. Structural alignment shows that these positively charged interface residues of DszAT, R278, R279 and K180, correspond to K276, R277 and R190 of FabD, maintaining the charge at the interface for interaction with an ACP partner. Active site, specificity-determining, and interface residues are shown in sticks.
Extended Data Fig. 6 Characterization of E. coli FabD transacylation activity with the DEBS PKS.
(A) Steady-state kinetic characterization of transacylation reaction of malonyl-CoA (left), methylmalonyl-CoA (middle) and fluoromalonyl-CoA (right) catalyzed by FabD with 75 μM of ACPDEBSMod6 as acyl accepter. Activity was measured by α-ketoglutarate dehydrogenase coupled assay, monitoring coenzyme A release by NADH fluorescence. Curves were obtained from non-linear curve fitting of data to Hill equation modified for substrate inhibition model. Table contains kcat, K0.5, kcat/K0.5, Ki and n values. Data shown are mean ± s.d of three technical replicates. Error in kcat/KM is obtained by propagation from individual kinetic terms. (B) In vitro triketide lactone assay for FabD complementation of Mod3DEBS + TE(AT0). Normalized representation of the amount of F-TKL (left), H-TKL (middle) and TKL (right) products are shown for reactions containing 10 μM Mod3DEBS + TE(AT0)), 30 μM FabD or WT DszAT, 1 mM NDK-SNAC, 1 mM fluoromalonate (left), malonate (middle) or methylmalonate (right), and 1 mM coenzyme A under regenerative condition. Reactions were quenched and analyzed by LC-QQQ after 24 h. The amounts of products were determined by integrating extracted ion counts for the relevant species (transition): F-TKL (175 → 157), H-TKL (157 → 139) and TKL (171 → 153). Data are mean of two technical replicates.
Extended Data Fig. 7 Influence of extender unit availability on the in vivo selectivity of chain elongation by single-modular DEBS constructs in engineered E. coli.
Concentrated cell suspension of E. coli BAP1 expressing Mod3DEBS + TE(AT0) (left) or Mod6DEBS + TE(AT0) (right), MatB and MadLM were provided with 1 mM NDK-SNAC and 5 mM fluoromalonate, malonate and/or methylmalonate and analyzed by LC-QQQ after 24 h. The concentrations of products were determined by integrating extracted ion counts for the relevant species (transition): F-TKL (175 → 157), H-TKL (157 → 139) and TKL (171 → 153), and comparing to external standard curves generated using synthetic standards of the molecules. Data revealed that the product profile follows the corresponding precursor profile, suggesting that the outcome is mainly governed by the provided precursors. Data are mean ± s.d. of three biological replicates.
Extended Data Fig. 8 In vivo production of desmethyl 6dEB analogs by engineered E. coli.
(A) Extracted ion chromatograms showing the production of 6dEB by E. coli expressing DEBS, Mod5 AT0 DEBS, or Mod6 AT0 DEBS. E. coli BAP1 harboring variants of pBP130 and pBP144 were grown to OD600 = 0.4–0.6 at 37 °C with shaking at 200 rpm, at which point protein expression was induced with 1 mM IPTG and 0.2% arabinose and cultures provided with 20 mM sodium propionate. Cultures were then incubated with substrates at 22 °C with shaking at 250 rpm for 1 day, after which, culture media were collected, extracted and analyzed. 6dEB product was monitored by LC-QQQ using transition 369.1→239.1. Chromatograms are representative of at least three biological replicates. (B) Extracted ion chromatograms showing the production of desmethyl-6dEB analogs by E. coli expressing DEBS, Mod5 AT0 DEBS, or Mod6 AT0 DEBS. Samples were prepared as in (A). Desmethyl-6dEB products were monitored by LC-QQQ using transition: 355.2→225.1. Chromatograms are representative of at least three biological replicates. (C) Fragmentation patterns of the desmethyl 6dEB analogs produced by E. coli harboring Mod5 AT0 DEBS (top) or Mod6 AT0 DEBS (bottom). The observed patterns are consistent with those of the desmethyl-6dEB analogs produced by in vitro reconstitution of corresponding enzyme systems. Spectra are representative of at least three biological replicates (nd, not detected).
Extended Data Fig. 9 Growth curves of E. coli BAP1 expressing pFmal plasmids.
Various E. coli BAP1 strains were grown to OD600 ~ 0.4 at 37 °C with shaking at 200 rpm, at which point 100 μL of culture was transferred to 96-well plate and induced with 1 mM IPTG/0.2% (w/v) arabinose. The no plasmid control strain (left), strain expressing only the MadLM transporter (middle) and strain expressing the MadLM transporter and MatB (right) were supplemented with 20 mM sodium propionate, 5 mM malonate or 5 mM fluoromalonate as noted in the legend. Cell growth was monitored at OD600 using a microplate reader. Data are representative of 3 biological replicates.
Extended Data Fig. 10 In vivo production of monofluorinated desmethyl 6dEB analogs by engineered E. coli.
(A) Fragmentation pattern and tabulated masses of daughter ions of monofluorinated desmethyl 6dEB analog produced by E. coli expressing Mod5 AT0 DEBS (top)or Mod6 AT0 DEBS (bottom). The observed patterns are consistent with those of the monofluorinated desmethyl-6dEB analogs produced by in vitro reconstitution of corresponding enzyme systems. Spectra are representative of at least three biological replicates. (B) 19F-NMR spectrum of 2-fluoro-2-desmethyl 6dEB isolated from culture media extract of E. coli expressing Mod6 AT0 DEBS, MatB and MadLM. Concentrated cell suspension was provided with 5 mM fluoromalonate and 20 mM propionate and incubated at 22 °C with shaking at 250 rpm. After 24 h incubation, culture medium was extracted with ethyl acetate, dried via rotary evaporation. 2-fluoro-2-desmethyl 6dEB was then purified from ethyl acetate extract of culture medium through HPLC and fractions were screened using LC-QQQ. Fractions showing presence of 2-fluoro-2-desmethyl 6dEB with transition 373.2 → 275.1 were combined, lyophilized and resuspended in 500 µL of 50:50 MeOH:D2O mixture for 19F-NMR analysis. Spectrum was collected on Bruker AV600 with following parameters: o1p = −200, sw = 200, d1 = 1 s, d0 -20, n = 3200. 5-fluorouracil (1 mM) was used as internal standard. Spectrum reveals a set of signals between -195 and -196 ppm displaying a doublet of doublet splitting pattern (J = 54, 12 Hz) consistent with the β-hydroxy-α-fluoro-carbonyl motif expected of 2-fluoro-2-desmethyl 6dEB. The observed chemical shift value is similar to that observed of other compounds with similar α-fluoro-β-hydroxy ester motif55. Based on vicinal coupling constant (3JF-H) and known (S)-orientation of hydroxy group on carbon 3, the observed molecule is assigned as 2-(R)-fluoro-2-desmethyl 6dEB.
Supplementary information
Supplementary Information
Supplementary Tables 1–3, Figs. 1–7 and Notes 1 and 2.
Supplementary Data
Numerical source data for Supplementary Figs. 5 and 6.
Supplementary Data
NMR FID Data for Extended Data Fig. 10.
Source data
Source Data Fig. 2
Numerical source data.
Source Data Fig. 3
Numerical source data.
Source Data Fig. 4
Numerical source data.
Source Data Fig. 5
Numerical source data.
Source Data Extended Data Fig. 1
Numerical source data.
Source Data Extended Data Fig. 2
Numerical source data.
Source Data Extended Data Fig. 3
Numerical source data.
Source Data Extended Data Fig. 4
Numerical source data.
Source Data Extended Data Fig. 6
Numerical source data.
Source Data Extended Data Fig. 7
Numerical source data.
Source Data Extended Data Fig. 8
Numerical source data.
Source Data Extended Data Fig. 9
Numerical source data.
Source Data Extended Data Fig. 10
Numerical source data.
Rights and permissions
About this article
Cite this article
Sirirungruang, S., Ad, O., Privalsky, T.M. et al. Engineering site-selective incorporation of fluorine into polyketides. Nat Chem Biol 18, 886–893 (2022). https://doi.org/10.1038/s41589-022-01070-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41589-022-01070-y
This article is cited by
-
Biocatalytic enantioselective C(sp3)–H fluorination enabled by directed evolution of non-haem iron enzymes
Nature Synthesis (2024)
-
Enzymology of assembly line synthesis by modular polyketide synthases
Nature Chemical Biology (2023)
-
Future challenges and opportunities with fluorine in drugs?
Medicinal Chemistry Research (2023)
-
Characterization of three succinyl-CoA acyltransferases involved in polyketide chain assembly
Applied Microbiology and Biotechnology (2023)